Ligand Pharmaceuticals Inc (LGND)
R&D Expense Growth
582.87%
Quarterly · Period ending:
LGND R&D Expense Growth
Latest reported582.87%period ending
Latest reported582.87%period ending
LGND Quarterly R&D Growth (QoQ) (0.00% → 582.87%)
Latest values, visible window
High-resolution chart · PNG
LGND r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 6.3362% | |
| -3.1389% | |
| -3.19% | |
| 3.6268% | |
| 2.1443% | |
| -14.3973% | |
| -7.0064% | |
| 7.5342% | |
| 0.6897% | |
| -32.5581% | |
| 26.4706% | |
| -1.7341% | |
| 16.1074% | |
| -29.0476% | |
| 16.6667% | |
| 7.7844% | |
| 0.6024% | |
| -4.0462% | |
| 15.3333% | |
| 1.3514% | |
| 20.3252% | |
| -7.5188% | |
| 9.9174% | |
| 0% | |
| -100% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |